
The whole is greater than the sum of its parts.
At Avisulting, we integrate strategic advisory expertise with practical consultation to deliver exceptional results. Guided by our core values—Trust, Transparency, and Together—we build strong partnerships with medtech, pharmaceutical and biotechnological companies, contract research organizations, and independent experts. We believe in open communication, mutual trust, and collaborative solutions to achieve success and foster lasting relationships. Join us in this collaborative journey towards excellence.

François BIANCHI, PhD
Founder and principal consultant.
As a seasoned expert in the life sciences sector, his career spanning over 20 years has been characterized by significant contributions to biocompatibility and Extractables and Leachables (E&L). His tenure at B. Braun Medical as the Head of Extractables and Leachables Studies Management highlights his ability to lead and innovate in this complex field. There, he transformed E&L testing processes through strategic oversight, developing and implementing SOPs and Work Instructions that simplified and enhanced E&L and primary packaging qualification processes.
Prior to this role, he worked at Johnson & Johnson, where he was involved in conducting the biocompatibility qualification (ISO-10993) of an implantable infusion pump, essential for FDA pre-market approval. This experience provided him with a robust foundation in the stringent requirements of biocompatibility assessments and regulatory compliance. Managing stability studies and biocompatibility risk assessments at Johnson & Johnson enhanced his expertise and prepared him for the complex challenges he would face in his professional journey at Ferring Pharmaceuticals, B. Braun Medical, Merck Serono, and Debiotech.
Throughout his career, he has developed a large network of trusted organizations, from analytical laboratories to biocompatibility services, with solid expertise in regulatory, quality, and toxicological subjects. These partnerships have been crucial in navigating the regulatory landscape and ensuring that all processes and products meet rigorous safety standards, further solidifying his reputation as a leader in biocompatibility and E&L within the life sciences industry.

Ary SAAMAN
Principal consultant partner.
Ary is a valued and enthusiastic member of my network. He has over 30 years of hands-on experience in the medical device and drug-device combination product industry, in particular in the fields of Technology Management, Quality Management, and Regulatory Affairs Management.
He acquired most of his experience while at Debiotech (Lausanne, Switzerland), a company renowned for developing innovative devices for delivering drugs to the human body as well as systems for home dialysis. He built up Debiotech’s Quality Management and Regulatory Affairs Management systems to proactively ensure compliance with EU and US FDA requirements.
He also fulfilled missions in the field of drug-device combination products for Alvotech (Reykjavik, Iceland) and CSL Behring (Bern, Switzerland).
He has been a longtime member of AAMI (Association for the Advancement of Medical Instrumentation of Arlington, Virginia, USA) and RAPS (Regulatory Affairs Professionals Society of Rockville, Maryland, USA). He is one of the founders of RAPS Switzerland Chapter and currently serves on the RAPS European Council.
He holds past and present teaching assignments for medical device development, quality, and regulatory affairs at, e.g., the EPFL (Swiss Federal Institute of Technology of Lausanne, Switzerland).
to benefit from our specialized and personalized Biocompatibility and E&L leadership.